Dimitris Voliotis

Dimitris Voliotis

Direttore Tecnico/Scientifico/R&S presso RADIOPHARM THERANOSTICS LIMITED
63 anni
Health Technology
Consumer Services
Health Services

Profilo

Dimitris Voliotis currently works at Radiopharm Theranostics Ltd., as Chief Medical Officer from 2024.
Dr. Voliotis also formerly worked at CureVac SE, as Chief Development Officer from 2019 to 2020, Eisai, Inc., as Global Head-Clinical Development Oncology from 2016 to 2019, Bayer HealthCare AG, as Vice President & Head-Oncology Group from 2007 to 2014, and Zentalis Pharmaceuticals, Inc., as Senior Vice President-Clinical Development from 2020 to 2023.
Dr. Voliotis received his doctorate degree from Universität zu Köln.

Posizioni attive di Dimitris Voliotis

SocietàPosizioneInizio
RADIOPHARM THERANOSTICS LIMITED Direttore Tecnico/Scientifico/R&S 20/08/2024

Precedenti posizioni note di Dimitris Voliotis

SocietàPosizioneFine
ZENTALIS PHARMACEUTICALS, INC. Corporate Officer/Principal 01/09/2023
Corporate Officer/Principal 01/02/2020
Corporate Officer/Principal 01/01/2019
Corporate Officer/Principal 01/09/2014
Vedi nel dettaglio l'esperienza di Dimitris Voliotis

Formazione di Dimitris Voliotis

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

29

Relazioni di 1° grado

6

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private6

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

  1. Mercati
  2. Insiders
  3. Dimitris Voliotis